237 related articles for article (PubMed ID: 31929987)
1. Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients.
Yang P; Javle M; Pang F; Zhao W; Abdel-Wahab R; Chen X; Meric-Bernstam F; Chen H; Borad MJ; Liu Y; Zou C; Mu S; Xing Y; Wang K; Peng C; Che X
Hepatobiliary Surg Nutr; 2019 Dec; 8(6):604-614. PubMed ID: 31929987
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.
de Bitter TJJ; de Reuver PR; de Savornin Lohman EAJ; Kroeze LI; Vink-Börger ME; van Vliet S; Simmer F; von Rhein D; Jansen EAM; Verheij J; van Herpen CML; Nagtegaal ID; Ligtenberg MJL; van der Post RS
NPJ Precis Oncol; 2022 Nov; 6(1):83. PubMed ID: 36335173
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Utility of Next-Generation Sequencing in Circulating Free DNA and a Comparison With Matched Tissue in Gallbladder Carcinoma.
Mishra S; Srivastava P; Pandey A; Shukla S; Agarwal A; Husain N
Lab Invest; 2024 Feb; 104(2):100301. PubMed ID: 38092180
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer.
Yu H; Xu Y; Gao W; Li M; He J; Deng X; Xing W
Front Oncol; 2022; 12():930611. PubMed ID: 36072793
[TBL] [Abstract][Full Text] [Related]
5. Precision oncology for gallbladder cancer: insights from genetic alterations and clinical practice.
Lin J; Dong K; Bai Y; Zhao S; Dong Y; Shi J; Shi W; Long J; Yang X; Wang D; Yang X; Zhao L; Hu K; Pan J; Sang X; Wang K; Zhao H
Ann Transl Med; 2019 Sep; 7(18):467. PubMed ID: 31700903
[TBL] [Abstract][Full Text] [Related]
6. Genomic profiling of gallbladder carcinoma: Targetable mutations and pathways involved.
Mishra S; Kumari S; Srivastava P; Pandey A; Shukla S; Husain N
Pathol Res Pract; 2022 Apr; 232():153806. PubMed ID: 35231860
[TBL] [Abstract][Full Text] [Related]
7. Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational Approach.
D'Afonseca V; Arencibia AD; Echeverría-Vega A; Cerpa L; Cayún JP; Varela NM; Salazar M; Quiñones LA
Cancer Inform; 2020; 19():1176935120922154. PubMed ID: 32546937
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive molecular profiling of extrahepatic cholangiocarcinoma in Chinese population and potential targets for clinical practice.
Xue L; Guo C; Zhang K; Jiang H; Pang F; Dou Y; Liu X; Lin H; Dong X; Zhao S; Yao M; Wang K; Feng Y; Gu W
Hepatobiliary Surg Nutr; 2019 Dec; 8(6):615-622. PubMed ID: 31929988
[TBL] [Abstract][Full Text] [Related]
9. Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications.
Kuipers H; de Bitter TJJ; de Boer MT; van der Post RS; Nijkamp MW; de Reuver PR; Fehrmann RSN; Hoogwater FJH
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771420
[TBL] [Abstract][Full Text] [Related]
10. Genomic Profiling of Chinese Cervical Cancer Patients Reveals Prevalence of DNA Damage Repair Gene Alterations and Related Hypoxia Feature.
Wen H; Guo QH; Zhou XL; Wu XH; Li J
Front Oncol; 2021; 11():792003. PubMed ID: 35071000
[TBL] [Abstract][Full Text] [Related]
11. Genomic
Li M; Liu F; Zhang F; Zhou W; Jiang X; Yang Y; Qu K; Wang Y; Ma Q; Wang T; Bai L; Wang Z; Song X; Zhu Y; Yuan R; Gao Y; Liu Y; Jin Y; Li H; Xiang S; Ye Y; Zhang Y; Jiang L; Hu Y; Hao Y; Lu W; Chen S; Gu J; Zhou J; Gong W; Zhang Y; Wang X; Liu X; Liu C; Liu H; Liu Y; Liu Y
Gut; 2019 Jun; 68(6):1024-1033. PubMed ID: 29954840
[TBL] [Abstract][Full Text] [Related]
12. Biliary cancer: Utility of next-generation sequencing for clinical management.
Javle M; Bekaii-Saab T; Jain A; Wang Y; Kelley RK; Wang K; Kang HC; Catenacci D; Ali S; Krishnan S; Ahn D; Bocobo AG; Zuo M; Kaseb A; Miller V; Stephens PJ; Meric-Bernstam F; Shroff R; Ross J
Cancer; 2016 Dec; 122(24):3838-3847. PubMed ID: 27622582
[TBL] [Abstract][Full Text] [Related]
13. Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies.
Wang S; Chen R; Tang Y; Yu Y; Fang Y; Huang H; Wu D; Fang H; Bai Y; Sun C; Yu A; Fan Q; Gu D; Yi X; Li N
Front Oncol; 2020; 10():536. PubMed ID: 32373528
[TBL] [Abstract][Full Text] [Related]
15. Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer.
Abdel-Wahab R; Yap TA; Madison R; Pant S; Cooke M; Wang K; Zhao H; Bekaii-Saab T; Karatas E; Kwong LN; Meric-Bernstam F; Borad M; Javle M
Sci Rep; 2020 Dec; 10(1):22087. PubMed ID: 33328484
[TBL] [Abstract][Full Text] [Related]
16. Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study.
Kawakami S; Takano S; Fukasawa M; Shindo H; Takahashi E; Fukasawa Y; Hayakawa H; Kuratomi N; Kadokura M; Hosomura N; Amemiya H; Kawaida H; Kono H; Maekawa S; Ichikawa D; Enomoto N
BMC Cancer; 2021 Nov; 21(1):1245. PubMed ID: 34798839
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418).
Mascarenhas E; Gelatti AC; Araújo LH; Baldotto C; Mathias C; Zukin M; Werutsky G; Pacheco P; Gomes R; de Castro G; Cordeiro de Lima VC
Thorac Cancer; 2021 Mar; 12(5):580-587. PubMed ID: 33314759
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive molecular profiling broadens treatment options for breast cancer patients.
Kawaji H; Kubo M; Yamashita N; Yamamoto H; Kai M; Kajihara A; Yamada M; Kurata K; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Mori H; Akiyoshi S; Oki E; Oda Y; Baba E; Mori M; Nakamura M
Cancer Med; 2021 Jan; 10(2):529-539. PubMed ID: 33274848
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy.
Zhang M; Qi C; Wang Z; Chen H; Zhao X; Zhang X; Zhou Y; Gao C; Bai Y; Jia S; Ji J
J Mol Med (Berl); 2021 Sep; 99(9):1311-1321. PubMed ID: 34057552
[TBL] [Abstract][Full Text] [Related]
20. Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.
Wang L; Zhai Q; Lu Q; Lee K; Zheng Q; Hong R; Wang S
Ann Med; 2021 Dec; 53(1):1358-1369. PubMed ID: 34396843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
